Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Yousry

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Neurology|May 13, 2009
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotypeM Rovaris, F Barkhof, M Calabrese, et al.
Neuroimage. Clinical|January 8, 2021
FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosisO Goodkin, F Prados, S B Vos, et al.
Neurology|December 31, 1997
Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosisF Barkhof, M Filippi, J H van Waesberghe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 26, 2010
MRI shows increased sciatic nerve cross sectional area in inherited and inflammatory neuropathiesC D J Sinclair, M A Miranda, P Cowley, et al.
Journal of Neurology|October 13, 2001
Improved interobserver agreement for visual detection of active T2 lesions on serial MR scans in multiple sclerosis using image registrationI L Tan, R A van Schijndel, F Fazekas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 27, 2011
Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathiesC D J Sinclair, J M Morrow, M A Miranda, et al.
Neurology|November 14, 2008
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisD R Altmann, B Jasperse, F Barkhof, et al.
Neurology|January 5, 2002
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MSP A Brex, P D Molyneux, P Smiddy, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Neurology|May 13, 2009
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotypeM Rovaris, F Barkhof, M Calabrese, et al.
Neuroimage. Clinical|January 8, 2021
FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosisO Goodkin, F Prados, S B Vos, et al.
Neurology|December 31, 1997
Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosisF Barkhof, M Filippi, J H van Waesberghe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 26, 2010
MRI shows increased sciatic nerve cross sectional area in inherited and inflammatory neuropathiesC D J Sinclair, M A Miranda, P Cowley, et al.
Journal of Neurology|October 13, 2001
Improved interobserver agreement for visual detection of active T2 lesions on serial MR scans in multiple sclerosis using image registrationI L Tan, R A van Schijndel, F Fazekas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 27, 2011
Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathiesC D J Sinclair, J M Morrow, M A Miranda, et al.
Neurology|November 14, 2008
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisD R Altmann, B Jasperse, F Barkhof, et al.
Neurology|January 5, 2002
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MSP A Brex, P D Molyneux, P Smiddy, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Pageof 10